Search

Search bills, members, committees and pages...

BIOGEN, INC.

35 federal lobbying filings, 2023 to 2026.

BIOGEN, INC. is a client on 35 federal lobbying filings, 2023 to 2026, reporting $1.8M across them. Biotechnology Company. Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

3 it has hired, by filings.

RegistrantFilingsReported
TODD STRATEGY GROUP15$750K
FEDERAL STREET STRATEGIES, LLC14$700K
DLA PIPER LLP (US)6$300K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20266$320K
202512$580K
20249$450K
20238$400K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues35
MMMMedicare/Medicaid29
TAXTaxation/Internal Revenue Code8
MEDMedical/Disease Research/Clinical Labs6
CPTCopyright/Patent/Trademark5
PHAPharmacy5
TRDTrade (domestic/foreign)5

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…1
S. 832EPIC Act of 20251

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2026 second_quarter$50KJul 21, 2026
BIOGEN, INC.TODD STRATEGY GROUP2026 second_quarter$50KJul 20, 2026
BIOGEN, INC.DLA PIPER LLP (US)2026 second_quarter$60KJul 20, 2026
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2026 first_quarter$50KApr 21, 2026
BIOGEN, INC.TODD STRATEGY GROUP2026 first_quarter$50KApr 20, 2026
BIOGEN, INC.DLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2025 fourth_quarter$50KJan 21, 2026
BIOGEN, INC.TODD STRATEGY GROUP2025 fourth_quarter$50KJan 21, 2026
BIOGEN, INC.DLA PIPER LLP (US)2025 fourth_quarter$60KJan 20, 2026
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2025 third_quarter$50KOct 21, 2025
BIOGEN, INC.TODD STRATEGY GROUP2025 third_quarter$50KOct 21, 2025
BIOGEN, INC.DLA PIPER LLP (US)2025 third_quarter$60KOct 20, 2025
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2025 second_quarter$50KJul 22, 2025
BIOGEN, INC.DLA PIPER LLP (US)2025 second_quarter$60KJul 21, 2025
BIOGEN, INC.TODD STRATEGY GROUP2025 second_quarter$50KJul 19, 2025
BIOGEN, INC.DLA PIPER LLP (US)2025 second_quarterJul 1, 2025
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2025 first_quarter$50KApr 21, 2025
BIOGEN, INC.TODD STRATEGY GROUP2025 first_quarter$50KApr 21, 2025
BIOGEN, INC.TODD STRATEGY GROUP2024 fourth_quarter$50KJan 22, 2025
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2024 fourth_quarter$50KJan 22, 2025
BIOGEN, INC.TODD STRATEGY GROUP2024 third_quarter$50KDec 16, 2024
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2024 third_quarter$50KOct 22, 2024
BIOGEN, INC.TODD STRATEGY GROUP2024 third_quarter$50KOct 21, 2024
BIOGEN, INC.FEDERAL STREET STRATEGIES, LLC2024 second_quarter$50KJul 23, 2024
BIOGEN, INC.TODD STRATEGY GROUP2024 second_quarter$50KJul 19, 2024